The Senate's health bill fails traditional tests on rolling back public welfare programs. But it still has a solid shot, says Matt Yglesias. » Read More
By: Dan Mangan
Most Americans oppose moves that are key provisions in Republican-written bills that would repeal and replace major parts of Obamacare. » Read More
By: Julia Belluz
Childbirth in the US is already inexcusably dangerous. The Senate health bill would make it worse, Vox reports. » Read More
Mylan was criticized last year after hiking EpiPen prices to $600, but has seen its stock surge after Donald Trump's election.
Republican efforts to repeal and replace Obamacare are being hampered by divisions within the GOP caucus over financial aid to customers.
The HPV vaccine is increasingly becoming the primary test for reducing cervical cancer deaths, STAT News reports.
An Obamacare repeal could promote 'job lock,' or staying at a job to get health insurance, New York Times reports.
Mylan CEO Heather Bresch shares her views on the pharmaceutical industry in an interview Friday on CNBC's "Power Lunch."
Republican Congressional leaders face pressure from conservatives to fully repeal Obamacare.
The number of American adults living with some form of hearing loss is expected to nearly double by 2060.
The drug, known as JCAR015, was being tested in adults with relapsed acute lymphoblastic leukemia, a rare and deadly blood cancer.
President Donald Trump told Congress that more needs to be done to bring down "artificially high" prices for drugs, while at the same time praising a drug that turns out to cost $300,000 per year.
Jim Cramer explained why investors should give the fast-growing tech companies the benefit of the doubt.
Jim Cramer went off the charts with Bob Lang to determine if pharma has more room to run.
Republicans considering proposals for repealing and replacing Obamacare face concerns over fewer people being covered.
Trump outlined his plan for an Obamacare replacement. The problem is, it doesn't match any of the GOP plans, says PolicyGenius CEO Jennifer Fitzgerald.
Shares of EpiPen maker Mylan climbed on the heels of the company reporting fourth-quarter earnings that topped expectations.
The stock slid sharply in morning trading before rebounding to climb about 1 percent higher Wednesday.
The hire signals Carl Icahn may be back, at a time when biotech valuations are 25 percent off their 2015 highs.
President Donald Trump and Republican lawmakers want to increase the tax advantages for accounts that will help you pay for health care.
President Donald Trump urged Democrats to work with Republicans in Congress to replace Obamacare, calling it a "disaster."
Steve Beshear defends the Affordable Care Act in the Democratic response to Trump's address.
As President Donald Trump details how he will change the Affordable Care Act, five patients describe how the law has affected them.
Get the best of CNBC in your inbox